Development and evaluation of enzymatically-degradable hydrogel microparticles for pulmonary delivery of nanoparticles and biologics
The emerging class of biologic drugs, including proteins, peptides, and gene therapies, are widely administered by injection, despite potential systemic side effects. Rational design of targeted carriers that can be delivered non-invasively, with reduced side effects, is essential for the success of...
| Main Author: | |
|---|---|
| Format: | Others |
| Published: |
2014
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/2152/23398 |